Results 231 to 240 of about 99,805 (324)

Antipsychotic Polypharmacy: Squandering Precious Resources?

, 2002
Stephen M. Stahl
openalex   +2 more sources

Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Immunosuppressive disease was associated with reduced overall survival, while anticoagulant use was linked to prolonged progression‐free survival in advanced cutaneous squamous cell carcinoma treated with immune checkpoint inhibitors. Host‐related factors may modulate immunotherapy efficacy and warrant prospective validation.
Glenn Geidel, Sabrina Bänsch, Laura Adam, Nathan Fekade, Alessandra Rünger, Tim Zell, Daniel J. Smit, Julian Kött, Isabel Heidrich, Michael Weichenthal, Selma Ugurel, Ulrike Leiter, Peter Mohr, Alexandra Geusau, Stephan Grabbe, Markus V. Heppt, Ralf Gutzmer, Jochen Utikal, Jan‐Christoph Simon, Sebastian Haferkamp, Laura Susok, Bastian Schilling, Edgar Dippel, Imke von Wasielewski, Jessica C. Hassel, Carola Berking, Stefan W. Schneider, Christoffer Gebhardt   +27 more
wiley   +1 more source

Association between polypharmacy and hypertension in the Iranian population aged 50 years or older: Iranian Multicenter Osteoporosis Study (IMOS-2021). [PDF]

BMC Prim Care
Bordbar S, Cheraghloo N, Salehi S, Khalagi K, Gharibzadeh S, Zarepour P, Khojasteh M, Tabatabaei-Malazy O, Larijani B.   +8 more
europepmc   +1 more source

Willingness to Participate in Deprescribing Trials: A Survey of Older Adults in Two Countries

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background This study investigates the willingness of older adults to participate in a hypothetical deprescribing clinical trial. Methods We conducted an online survey of adults aged 65+ years in Australia and the United States. Participants rated their willingness to enroll in a deprescribing trial, responding to the statement, “Research is ...
Sarah E. Vordenberg, Noelia Dulo, Alexander Chaitoff, Kirsten Ingwersen, Kristie Rebecca Weir   +4 more
wiley   +1 more source

Polypharmacy following Dementia Diagnoses in Vietnam: Results from Real-World Data in Outpatient Settings.

Gerontology
Hoang MT, Le NT, Hoai Nguyen TT, Nguyen TD, Nguyen TX, Nguyen AN, Dang TK, Nguyen BT, Thanh Nguyen HT, Pham T, Nguyen AT, Nguyen TA, Thanh Vu HT.   +12 more
europepmc   +1 more source

The Double Burden of the COVID-19 Pandemic and Polypharmacy on Geriatric Population – Public Health Implications

, 2020
Saifur Rahman, Keshav Singh, Sameer Dhingra, Jaykaran Charan, Purushottam Sharma, Sheikh Mohammed Shariful Islam, Dilshad Jahan, Kristy Iskandar, Nandeeta Samad, Haque M   +9 more
openalex   +1 more source

<p>Core Patient-Reported Outcomes (PROs) and PRO Measures (PROMs) for Polypharmacy Medicines Reviews: A Sequential Mixed-Methods Study</p>

, 2019
Grigorios Kotronoulas, Mark Cooper, Bridget Johnston   +2 more
openalex   +2 more sources

Frailty and Health Outcomes in People 65 Years or Older Living With Dementia: A Systematic Review of the Literature

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Introduction Although frailty is considered a potentially modifiable risk factor for dementia, its influence on health outcomes in individuals with established dementia remains unclear. This study aims to systematize the current evidence to understand the impact of frailty on the development of adverse outcomes in older adults with dementia ...
Miguel German Borda, Luis Carlos Venegas‐Sanabria, Marco Canevelli, Francesco Landi, Salomón Páez‐García, Kevin O'Hara‐Veintimilla, Lindsay Wallace, Kenneth Rockwood, Tommy Cederholm, Gustavo Duque, Mario Ulises Pérez‐Zepeda, Dag Aarsland   +11 more
wiley   +1 more source

Why is the skeleton still in the hospital closet? A look at the complex aetiology of protein-energy malnutrition and its implications for the nutrition care team [PDF]

, 2018
Marshall, S.
core   +1 more source

Development and Implementation of a Medical Cannabis Clinic Within a Geriatrics Primary Care Clinic: Preliminary Data

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Cannabis use is rising among adults, yet few users receive structured medical supervision. Older users face unique risks necessitating specialized oversight. Given their longitudinal relationships and detailed understanding of patients' health and goals, primary care providers are well‐positioned to guide decisions and education ...
Ryan Weaver, Brian Velez, Michael L. Weissberger, Kristin M. Zimmerman   +3 more
wiley   +1 more source